The knock-on effects of these cuts has also seen an increase of over 61,000 hospital admissions since 2012 at an estimated cost of £317m to the NHS. More: Cuts in alcohol duty linked to 2000 deaths Source: News
read more84% of Brits fear losing their sight more than any other sense. More: 1/3 of people with sight loss suffer mental health problems Source: News
read moreThe pharma industry has a reputation problem, and presidential candidates have voiced various ideas for lowering drug prices. Merck CEO Ken Frazier knows the industry is in the political “crosshairs,” but he cautioned against policies that could “hurt innovation.” More:
read moreCan a decades-old drug with “substantial uncertainty” over its clinical evidence still win public health coverage in England? In bladder pain drug Elmiron’s case, the answer is “yes”—but not without a price discount and some use restrictions. More: NICE backs
read moreMore: Manufacturing News of Note—Thermo Fisher closes on GSK plant; Vetter invests 0M; Lupin names ex-Apotex exec head of quality Source: fierce
read moreNovartis this week won FDA approval for Beovu, a wet AMD med that’s expected to become a blockbuster. But the drug will be going up against entrenched rivals with some blemishes in its label, analysts wrote. The label doesn’t specifically
read more© 1994 - 2026 B.M. Pharmaceuticals